查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1659425

全球次世代定序仪(NGS) 样品製备市场

Next Generation Sequencing (NGS) Sample Preparation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 88 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球次世代定序仪(NGS) 样品製备市场规模将达到 105 亿美元

2024 年全球次世代定序仪(NGS) 样品製备市场规模估计为 39 亿美元，预计到 2030 年将达到 105 亿美元，2024 年至 2030 年的复合年增长率为 18.2%。试剂和消耗品是报告中分析的细分市场之一，预计到分析期结束时复合年增长率为 19.7%，达到 69 亿美元。在分析期间内，工作站部分的复合年增长率预计为 15.5%。

美国市场预估达 11 亿美元，中国市场复合年增长率达 17.0%

预计 2024 年美国次世代定序仪(NGS) 样品製备市场规模将达 11 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 16 亿美元，2024-2030 年分析期间的复合年增长率为 17.0%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 16.0% 和 15.2%。在欧洲，预计德国的复合年增长率约为 13.0%。

全球次世代定序仪(NGS) 样品製备市场 - 主要趋势与驱动因素摘要

次世代定序仪（NGS）样本製备将如何推动基因组学的发展？

次世代定序仪(NGS) 样本製备是基因组序列测定过程中的关键步骤，可实现对 DNA 和 RNA 的准确分析，以用于研究、临床诊断和个人化医疗。该过程包括 DNA/RNA 萃取、文库製备和目标富集，所有这些对于获得高品质的定序结果至关重要。随着自动化、多路復用和单细胞分析等创新的出现，NGS 样品製备取得了重大进展，从而实现了更快、更准确的基因组分析。随着基因组学成为了解疾病、药物开发和群体遗传学不可或缺的一部分，高效的样品製备对于充分发挥 NGS 技术的潜力至关重要。

NGS 样品製备市场的关键部分有哪些？

主要产品包括试剂、套件、仪器和耗材，其中试剂和套件占据市场主导地位，常用于文库製备和目标富集。工作流程包括 DNA 萃取、文库製备和目标富集，其中文库製备是最大的部分。主要最终用户包括学术研究机构、医院、製药公司和临床实验室，他们都使用 NGS 样本製备来进行基因组研究、开发个人化治疗方法和诊断遗传疾病。

NGS 样品製备是如何跨学科应用的？

学术研究机构是NGS样本製备的最大用户，将其用于基因组研究、基因表现研究和生物标记发现。医院和临床实验室使用NGS样本製备来诊断遗传疾病、检测感染疾病并指导个人化治疗方案。製药公司利用基因组数据来确定基因标靶、开发新药、进行临床试验，基因组资料在药物疗效分析中发挥重要作用。人们对群体遗传学和精准医疗的兴趣日益浓厚，进一步推动了政府资助的基因组计划和需要大规模定序进行基因分析的生物库采用NGS样本製备。

哪些因素推动了NGS样品製备市场的成长？

下一代定序样本製备市场的成长受到多种因素的推动，包括疾病研究、个人化医疗和药物开发对基因组学的需求不断增加。自动化和多路復用技术的进步提高了样品製备的效率和准确性，并提高了整体 NGS 工作流程的速度。精准医疗的兴起严重依赖基因洞察，这进一步增加了对先进样本製备技术的需求。政府对基因组研究的倡议和资助，加上临床基因组学的扩展，促进了市场的成长。 NGS 在癌症诊断、罕见疾病检测和感染疾病监测中的应用日益增多，也推动了高效样品製备解决方案的需求。

部分

产品类型（试剂和耗材、工作站）、工作流程（半自动化文库製备、 NGS库製备套件、自动化文库製备、克隆扩增）、应用（肿瘤学、消费者基因总体基因体学、流行病学和研发、农业基因组学和法医学、 HLA型检测和免疫製药系统监测、其他学术应用程式和研究

受访公司范例（总合32家公司）

  • Agilent Technologies
  • Beckman Coulter（A Subsidiary of Danaher）
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen NV
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP22379

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach US$10.5 Billion by 2030

The global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$3.9 Billion in the year 2024, is expected to reach US$10.5 Billion by 2030, growing at a CAGR of 18.2% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.7% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in the Workstations segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 17.0% CAGR

The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 17.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Next Generation Sequencing (NGS) Sample Preparation Market - Key Trends and Drivers Summarized

How Is Next Generation Sequencing (NGS) Sample Preparation Evolving Genomics?

Next Generation Sequencing (NGS) Sample Preparation is a crucial step in the genomic sequencing process, enabling the accurate analysis of DNA and RNA for research, clinical diagnostics, and personalized medicine. This process involves DNA/RNA extraction, library preparation, and target enrichment, all of which are critical for obtaining high-quality sequencing results. NGS sample preparation has advanced significantly with innovations such as automation, multiplexing, and single-cell analysis, allowing for faster and more precise genomic analysis. As genomics becomes integral to understanding diseases, drug development, and population genetics, efficient sample preparation is essential for unlocking the full potential of NGS technologies.

What Are the Key Segments in the NGS Sample Preparation Market?

Key products include reagents, kits, instruments, and consumables, with reagents and kits dominating the market due to their frequent use in library preparation and target enrichment. In terms of workflow, the market covers DNA extraction, library preparation, and target enrichment, with library preparation being the largest segment. Major end-users include academic research institutions, hospitals, pharmaceutical companies, and clinical laboratories, all of which use NGS sample preparation to conduct genomic studies, develop personalized therapies, and diagnose genetic disorders.

How Is NGS Sample Preparation Being Adopted Across Sectors?

Academic research institutions are the largest users of NGS sample preparation, utilizing it for genomic research, gene expression studies, and biomarker discovery. Hospitals and clinical laboratories leverage NGS sample preparation for diagnosing genetic disorders, detecting infectious diseases, and guiding personalized treatment plans. Pharmaceutical companies use it to identify genetic targets, develop new drugs, and conduct clinical trials, where genomic data plays a critical role in drug efficacy analysis. The growing interest in population genetics and precision medicine is further driving the adoption of NGS sample preparation in government-funded genomic projects and biobanks, which require large-scale sequencing for genetic analysis.

What Factors Are Driving the Growth in the NGS Sample Preparation Market?

The growth in the Next Generation Sequencing Sample Preparation market is driven by several factors, including the increasing demand for genomics in disease research, personalized medicine, and drug development. Technological advancements in automation and multiplexing have improved the efficiency and accuracy of sample preparation, enhancing the overall speed of NGS workflows. The rise of precision medicine, which relies heavily on genetic insights, has further fueled the need for advanced sample preparation techniques. Government initiatives and funding for genomic research, coupled with the expansion of clinical genomics, are contributing to market growth. The increasing use of NGS in cancer diagnostics, rare disease detection, and infectious disease monitoring is also driving the demand for efficient sample preparation solutions.

SCOPE OF STUDY:

The report analyzes the Next Generation Sequencing (NGS) Sample Preparation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Consumables, Workstations); Workflow (Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation, Clonal Amplification); Application (Oncology, Consumer Genomics, Metagenomics, Epidemiology & Drug Development, Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications); End-Use (Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 32 Featured) -

  • Agilent Technologies
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Next Generation Sequencing (NGS) Sample Preparation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Sequencing Spurs Growth in NGS Sample Preparation Market
    • Technological Advancements in Automation and Library Preparation Kits Strengthen Business Case for Adoption
    • Growing Focus on Precision Medicine and Genomic Research Expands Addressable Market for NGS Sample Preparation
    • Expansion of NGS Sample Preparation in Academic Research and Clinical Laboratories Fuels Market Growth
    • Increasing Adoption of NGS Sample Preparation in Cancer Genomics, Infectious Disease, and Genetic Disorders Expands Market Opportunities
    • Technological Innovations in Single-Cell Sequencing and RNA Sequencing Propel Market Expansion
    • Rising Focus on Reducing Turnaround Time and Cost per Sample Drives Demand for NGS Sample Preparation
    • Growing Use of NGS Sample Preparation in Pharmacogenomics and Drug Development Expands Market Potential
    • Technological Advancements in Multiplex PCR, Target Enrichment, and Library Construction Propel Market Growth
    • Increasing Focus on Integrating NGS Sample Preparation with Bioinformatics Pipelines Drives Adoption
    • Rising Demand for NGS Sample Preparation in Plant Genomics, Microbiome, and Epigenetics Research Strengthens Global Market
    • Expansion of NGS Sample Preparation in Liquid Biopsy and Minimal Residual Disease Testing Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Semi-Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Semi-Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for NGS Library Preparation Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for NGS Library Preparation Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clonal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Clonal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Metagenomics, Epidemiology & Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Metagenomics, Epidemiology & Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agrigenomics & Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Agrigenomics & Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for HLA Typing / Immune System Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for HLA Typing / Immune System Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 22: World 6-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World 6-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World 6-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Pharma & Biotech Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 28: World 6-Year Perspective for Pharma & Biotech Entities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 31: World Next Generation Sequencing (NGS) Sample Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Workstations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Workstations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • JAPAN
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • CHINA
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • EUROPE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • FRANCE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • GERMANY
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • UNITED KINGDOM
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2025 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2025 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2025 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of World 6-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2025 & 2030

IV. COMPETITION